The Enterprise Value as of December 2025 (TTM) for Cullinan Therapeutics, Inc. (CGEM) is 522.87M

According to Cullinan Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 522.87M. This represents a change of 64.08% compared to the average of 318.67M of the last 4 quarters.

Cullinan Therapeutics, Inc. (CGEM) Historical Enterprise Value (quarterly & annually)

How has CGEM Enterprise Value performed in the past?

The mean historical Enterprise Value of Cullinan Therapeutics, Inc. over the last ten years is 420.28M. The current 522.87M Enterprise Value has changed 12.34% with respect to the historical average. Over the past ten years (40 quarters), CGEM's Enterprise Value was at its highest in in the March 2021 quarter at 1.46B. The Enterprise Value was at its lowest in in the September 2025 quarter at -102147000.00.

Cullinan Therapeutics, Inc. (CGEM) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Cullinan Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Cullinan Therapeutics, Inc. (CGEM) Average Enterprise Value

How has CGEM Enterprise Value performed in the past?

The current Enterprise Value of Cullinan Therapeutics, Inc. (CGEM) is greater than its 3-year, less than than its 5-year, and greater than its 10-year historical averages

Cullinan Therapeutics, Inc. (CGEM) Enterprise Value vs. Peers

How is CGEM’s Enterprise Value compared to its peers?

Cullinan Therapeutics, Inc.’s Enterprise Value is greater than Standard BioTools Inc. (451.75M), less than So-Young International Inc. (2.79B), greater than ADC Therapeutics S.A. (262.56M), less than RAPT Therapeutics, Inc. (534.71M), less than CeriBell, Inc. (707.99M), less than Enhabit, Inc. (965.45M), greater than Varex Imaging Corporation (362.66M), greater than Neumora Therapeutics, Inc. Common Stock (251.41M), less than Omeros Corporation (883.69M), greater than Bicycle Therapeutics plc (-152624053.00),

Build a custom stock screener for Cullinan Therapeutics, Inc. (CGEM) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cullinan Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Cullinan Therapeutics, Inc. (CGEM) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Cullinan Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.